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Background
1-Pilot the PNEP in the Iranian prisons after having
received the acceptance of the authorities in the Iranian
Judiciary System. 2-Schedule the piloting of the PNEP in
the Iranian prisons. 3-Analyse the opinions given by the
policy-makers in prisons and the staff to have a better
implementation of the programme. (during pre-, while
and post-stages) 4-Collect and evaluate demographic
crime and drug data of the IDU’s who are easily reached
since in this program the IDU’s can quite easily mention
their difficulties with drugs. 5 - Distribute the sterile syr-
inges among the IDU’s without any limitations and eval-
uate the data based on the number of sterile received
and used returned syringes respectively.
Methods
After recieving acceptance of policy-makers, program
performed in 3 prisons and all the volunteers were IV
drug abusers. The program had been performed in three
major prison centers in Iran, including Tehran, Isfahan
and Hamadan. The prisoners were given sterile needles
and syringes weekly, and the used ones were also col-
lected regularly. Data including number of syringes and
shared ones used by each person was collected at the
beginning of program; and this data was also documen-
ted on a weekly basis as the program proceeded. Infor-
mation regarding blood-borne diseases was also given to
the enrolled prisoners continuously.
Results
Among 341 volunteer prisoners enrolled in this pro-
gram, an average of 17 syringes was reported to be used
weekly for IV drug injection before starting the pro-
gram. Moreover, the volunteers reported to use an aver-
age of 3.7 shared syringes during a week. Documented
infection with blood-borne diseases (including Human
Immunodefficiency Virus, Hepatitis B or C) was also
found in 44 prisoners. At the end of the program, preva-
lence of using shared syringes among volunteers was
decline to zero.
Discussion
1-Iran Prisons Organisations will be going to extend the
programme to the rest of the Iranian prisons in case the
results are satisfactory and there are minor complica-
tions.2-Voluntary entrance of the prisoners into the
PNEP shows that despite the access to the other harm
reduction programmes, the need and desire to inject
drugs will not disappear and if the prisoners are not
given sterile syringes and needles, they will share them.
3-Programming, process, problems and their solutions
during the programme can be of great help to the rest
of the Iranian prisons and other prisons worldwide. 4-
The average number of prisoners who entered the pro-
gramme in the three target prisons has been between 25
and 35 per month and the volunteer prisoners have
always intended to use syringes. 5-The average age of
starting the injection has been 25 which simply shows a
young majority which can help spread the diseases in
the society more rapidly. And almost half of the men-
tioned prisoners are married and will act as a bridge to
spread the disease in the society in a faster pace. 6-The
other demographic characteristics of this group of IDU’s
including education, profession, etc. should be consid-
ered in harm reduction programmes planning. 7-The
high frequency of drug-related crimes shows the neces-
sity and importance of considering these prisoners in
harm reduction programmes. 8-As mentions by the
IDU’s, they inject drugs three times a day and this figure
can help in determining the number of needed syringes
during syringe distribution. 9-A high proportion of pris-
oners have no laboratory records of HIV, HCV and * Correspondence: mohamad.shahbazi@yahoo.com
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© 2010 Shahbazi et al; licensee BioMed Central Ltd.HBV while this is the most high risk group and access
to consulting services and laboratory tests must be
made available for them. 10-The high proportion of
prisoners with multiple partners has made this group
very special in harm reduction programmes and if not
properly controlled, they can be infected by HIV easily
and the virus is then spread among the partners and
later to the society. Syringe distribution among these
prisoners can help reduce the problem.
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